Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Macrophages sense and kill bacteria through carbon monoxide–dependent inflammasome activation
Barbara Wegiel, … , Miguel P. Soares, Leo E. Otterbein
Barbara Wegiel, … , Miguel P. Soares, Leo E. Otterbein
Published October 8, 2014
Citation Information: J Clin Invest. 2014;124(11):4926-4940. https://doi.org/10.1172/JCI72853.
View: Text | PDF
Research Article Immunology

Macrophages sense and kill bacteria through carbon monoxide–dependent inflammasome activation

  • Text
  • PDF
Abstract

Microbial clearance by eukaryotes relies on complex and coordinated processes that remain poorly understood. The gasotransmitter carbon monoxide (CO) is generated by the stress-responsive enzyme heme oxygenase-1 (HO-1, encoded by Hmox1), which is highly induced in macrophages in response to bacterial infection. HO-1 deficiency results in inadequate pathogen clearance, exaggerated tissue damage, and increased mortality. Here, we determined that macrophage-generated CO promotes ATP production and release by bacteria, which then activates the Nacht, LRR, and PYD domains-containing protein 3 (NALP3) inflammasome, intensifying bacterial killing. Bacterial killing defects in HO-1–deficient murine macrophages were restored by administration of CO. Moreover, increased CO levels enhanced the bacterial clearance capacity of human macrophages and WT murine macrophages. CO-dependent bacterial clearance required the NALP3 inflammasome, as CO did not increase bacterial killing in macrophages isolated from NALP3-deficient or caspase-1–deficient mice. IL-1β cleavage and secretion were impaired in HO-1–deficient macrophages, and CO-dependent processing of IL-1β required the presence of bacteria-derived ATP. We found that bacteria remained viable to generate and release ATP in response to CO. The ATP then bound to macrophage nucleotide P2 receptors, resulting in activation of the NALP3/IL-1β inflammasome to amplify bacterial phagocytosis by macrophages. Taken together, our results indicate that macrophage-derived CO permits efficient and coordinated regulation of the host innate response to invading microbes.

Authors

Barbara Wegiel, Rasmus Larsen, David Gallo, Beek Yoke Chin, Clair Harris, Praveen Mannam, Elzbieta Kaczmarek, Patty J. Lee, Brian S. Zuckerbraun, Richard Flavell, Miguel P. Soares, Leo E. Otterbein

×

Figure 2

Role of HO-1 and CO in IL-1β activation in macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Role of HO-1 and CO in IL-1β activation in macrophages.
(A) IL-1β ELISA ...
(A) IL-1β ELISA and immunoblot in BMDMs ± selective HO-1 inhibitors Sn-PP-IX and QC-15 ± CO started 4 hours after bacteria administration (106 CFU/ml) for 6 hours. Note that CO reversed the loss in HO-1 activity found in air treatment. *P < 0.05, air versus air + Sn-PP-IX; &P < 0.01, air versus CO; #P < 0.02, CO + Sn-PP-IX versus Sn-PP-IX. (B) Upper panel: IL-1β in BMDMs from the indicated mice ± E. coli (104 CFU/ml) ± CO as above. Note that CO rescues the IL-1β response in LyzM-Cre Hmox1fl/fl that is absent in air-treated controls (comparing lanes 2 and 5). Lower panel: immunoblot showing disappearance of HO-1 in LyzM-Cre Hmox1fl/fl differentiated over 5 days in response to MCSF (20 ng/ml). Note that as the Lyz promoter becomes active, HO-1 expression decreases. (C) Representative IL-1β and active caspase-1 p20 immunoblots in BMDMs. CO was administered for 6 hours starting 4 hours following E. faecalis infection (106 CFU/ml). (D) TNF ELISA in supernatants from BMDMs infected with E. faecalis as above. All blots represent 2 to 3 independent experiments expressed relative to β-actin as loading control. All ELISA data represent mean ± SD of 2 to 3 independent experiments in triplicate.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts